Selank is a Russian peptide developed as an anti-anxiety agent — and its selling point is appealing: calm without the sedation, dependence or withdrawal that make benzodiazepines a double-edged sword. It is an approved medicine in Russia and is studied for generalized anxiety.
The honest caveat is familiar for Russian peptides: most of the evidence comes from Russian research, with few large Western trials. Here is how Selank works, what the studies show, and why it is a research compound here rather than a prescription you can get from your doctor.
What Selank is
Selank is a synthetic heptapeptide based on tuftsin, a naturally occurring immune-modulating peptide, modified to last longer in the body. It was developed in Russia, where it is an approved medicine for anxiety. In the West it has no such approval and exists mainly as a research peptide and grey-market anxiolytic. For the basics, see Selank vs Semax.
Selank’s pitch is the holy grail of anti-anxiety: the calm of a benzodiazepine without the fog, the tolerance, or the withdrawal. The research is promising — and mostly Russian.Why Selank intrigues and frustrates in equal measure
How it works
Selank is described as a GABA-A system modulator — it influences the same calming neurotransmitter system that benzodiazepines act on, but in a gentler, modulatory way rather than a heavy sedating one. It is also studied for raising BDNF (a growth factor tied to mood and resilience), for effects on serotonin and dopamine balance, and — via its tuftsin origin — for immune-modulating actions. The combination is what researchers think produces an anxiolytic effect without the classic benzodiazepine downsides.
What the research shows
Russian clinical studies have compared Selank to benzodiazepines in generalized anxiety disorder, reporting comparable anxiety reduction with a better side-effect profile — notably without the heavy sedation, cognitive dulling, tolerance and withdrawal that limit benzodiazepines. Some studies also noted improvements in attention and a mild pro-cognitive effect. That is a genuinely attractive profile. The limitation is that this evidence base is largely Russian and not matched by large, independent Western randomized trials.
Selank vs benzodiazepines
| Selank | Benzodiazepines | |
|---|---|---|
| Effect on anxiety | Reduces (Russian studies) | Strong, fast |
| Sedation | Minimal reported | Common |
| Dependence / withdrawal | Not characteristic | Significant risk |
| Cognitive effect | Possibly mild pro-cognitive | Often dulling |
| Approval | Russia only | Widely approved |
| Evidence base | Mostly Russian | Extensive, global |
On paper Selank looks like a gentler tool. But benzodiazepines, for all their downsides, have an enormous, global evidence base and clear approved use — something Selank lacks outside Russia.
The evidence gap
Be clear-eyed: approved in Russia is not the same as proven to Western regulatory standards, and the online nootropic enthusiasm for Selank runs ahead of independent controlled data. We lack large Western trials and long-term safety data in healthy users. “Promising, used clinically in one country” is accurate; “proven anti-anxiety treatment” is not. If anxiety is affecting your life, the evidence-based path is a doctor and established treatments — see anxiety research in Canada.
Selank is not an approved drug in Canada, and injectable or intranasal peptides are regulated as prescription drugs here. It is not a substitute for proper care of anxiety, which is treatable — please talk to a doctor. TrueLabs sells Selank for in vitro and laboratory research only; this is research background, not medical advice or dosing guidance.
Selank vs Semax
The two Russian peptides are frequently paired: Selank leans anti-anxiety and calm, Semax leans focus and cognition. People researching one usually look at the other. The comparison is in Selank vs Semax, and the cognition side in Semax for cognition.
For researchers
TrueLabs supplies Selank from $40 and Semax from $41, the two best-known Russian neuropeptides, in CAD for in vitro and laboratory research only. Before ordering, see how to read a peptide COA and the COA library.
Selank myths
“Myth: Selank is a proven anxiety cure.”
It is approved in Russia and promising there, but lacks large independent Western trials. It is not an established, proven treatment here.
“Myth: It is a natural, risk-free benzo.”
It appears gentler than benzodiazepines, but long-term safety in healthy users is not well characterized, and it is unapproved here.
“Myth: It works instantly like Xanax.”
Its mechanism is modulatory (GABA, BDNF), generally described as calmer and less acutely sedating than a benzodiazepine hit.
“Myth: Research Selank can treat your anxiety.”
It is an unapproved raw compound for lab use, not a treatment. Anxiety deserves proper medical care.
FAQ
Tap a question to reveal the answer.
Does Selank work for anxiety?
Russian clinical studies report it reduces generalized anxiety, comparably to benzodiazepines but with less sedation and no characteristic dependence. The evidence is mostly Russian, without large Western trials.
How does Selank work?
It modulates the GABA system (the calming pathway benzodiazepines act on), is studied for raising BDNF, and affects serotonin and dopamine balance, with immune-modulating actions from its tuftsin origin.
Is Selank better than benzodiazepines?
Its profile looks gentler — less sedation, no characteristic dependence — but benzodiazepines have a vast global evidence base and approved use that Selank lacks outside Russia.
Is Selank addictive?
Dependence and withdrawal are not characteristic of Selank in the available studies, which is a key claimed advantage over benzodiazepines. Long-term human data are still limited.
Is Selank approved in Canada?
No. It is approved in Russia but not in Canada or the US, and peptides are regulated as prescription drugs here. TrueLabs sells it for research only.
What is the difference between Selank and Semax?
Selank leans anti-anxiety and calm; Semax leans focus and cognition. Both are Russian neuropeptides often studied together.
Is Selank safe?
It has been used clinically in Russia with a favourable side-effect profile, but long-term safety in healthy users is not well characterized and it is not approved here.
Is research Selank a treatment?
No. It is a raw compound for laboratory study, not an approved anxiety treatment. Anxiety is treatable — see a doctor.
Related reading
- Selank vs Semax
- Semax for cognition
- Selank side effects
- Anxiety research in Canada
- Brain fog: causes and research
References
- Zozulya AA, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in anxiety disorders. (Russian clinical research).
- Health Canada. Advisory: unauthorized injectable peptide products, 2025.
This article summarizes published research for information only and is not medical advice. TrueLabs research compounds are sold for in vitro and laboratory research use only and are not intended for human or veterinary use.